Clinical Trial Update: Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on the immunogenicity and tolerability of two strategies for Hepatitis A vaccination in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis A

Drugs mentioned

• Hepatitis A vaccine (inactivated Hepatitis A vaccine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: HIV Infection | Phase 3 | Status: COMPLETED